ID: h-debate-95c109a91f74
Hypothesis

Ganglioside Rebalancing Therapy via ST3GAL5 Modulation

Selective enhancement of ST3GAL5 (GM3 synthase) activity to restore optimal GM1/GM3 ratios and prevent amyloid nucleation at lipid rafts.
🧬 ST3GAL5🎯 Composite 0%💱 $0.51▲1.1%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite

🧪 Overview

Selective enhancement of ST3GAL5 (GM3 synthase) activity to restore optimal GM1/GM3 ratios and prevent amyloid nucleation at lipid rafts. This approach would reduce pathological GM1 accumulation that serves as a seed for Aβ fibril formation while maintaining essential ganglioside functions.

Debate provenance: derived from debate `sess_SDA-2026-04-04-frontier-lipidomics-dcdbc360` on question: How do alterations in brain lipid metabolism—including gangliosides, phospholipids, cholesterol transport, and sphingolipids—contribute to amyloidogenesis, tau pathology, and synaptic dysfunction in Alzheimer disease? Examine: (1) APOE-lipid particle composition and functional consequences, (2) gang. Consensus signal: domain_expert, synthesizer, theorist discussed the mechanism terms GM1, GM1/GM3, GM3, Ganglioside, Modulation, Rebalancing, ST3GAL5, modulation. Novelty signal: synthesizer-consensus.

🧬 Mechanism

🔗 Mechanism from KG for ST3GAL5

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    Poorly_lipidated_APOE["Poorly lipidated APOE"] -->|associated with| Alzheimer_s_disease_risk["Alzheimer's disease risk"]
    poorly_lipidated_APOE["poorly_lipidated_APOE"] -->|risk factor for| Alzheimer_disease["Alzheimer_disease"]
    ABCA1["ABCA1"] -->|activates| APOE_lipidation["APOE_lipidation"]
    properly_lipidated_APOE["properly_lipidated_APOE"] -->|prevents| tau_hyperphosphorylation["tau_hyperphosphorylation"]
    ABCA1_dysfunction["ABCA1 dysfunction"] -->|causes| brain_cholesterol_homeost["brain cholesterol homeostasis impairment"]
    ABCA1_dysfunction_1["ABCA1 dysfunction"] -->|accelerates| neurodegeneration["neurodegeneration"]
    Lipidated_APOE["Lipidated APOE"] -->|enhances| microglial_A__phagocytosi["microglial Aβ phagocytosis"]
    Lipidated_APOE_2["Lipidated APOE"] -->|enhances| A__clearance["Aβ clearance"]
    Elevated_ceramide_levels["Elevated ceramide levels"] -->|biomarker for| AD_severity["AD severity"]
    Elevated_ceramide_levels_3["Elevated ceramide levels"] -->|associated with| cognitive_decline["cognitive decline"]
    S1P["S1P"] -->|promotes| neuronal_survival["neuronal survival"]
    S1P_4["S1P"] -->|promotes| synaptic_plasticity["synaptic plasticity"]
    style Poorly_lipidated_APOE fill:#4fc3f7,stroke:#333,color:#000
    style Alzheimer_s_disease_risk fill:#4fc3f7,stroke:#333,color:#000
    style poorly_lipidated_APOE fill:#4fc3f7,stroke:#333,color:#000
    style Alzheimer_disease fill:#ef5350,stroke:#333,color:#000
    style ABCA1 fill:#ce93d8,stroke:#333,color:#000
    style APOE_lipidation fill:#4fc3f7,stroke:#333,color:#000
    style properly_lipidated_APOE fill:#4fc3f7,stroke:#333,color:#000
    style tau_hyperphosphorylation fill:#4fc3f7,stroke:#333,color:#000
    style ABCA1_dysfunction fill:#4fc3f7,stroke:#333,color:#000
    style brain_cholesterol_homeost fill:#4fc3f7,stroke:#333,color:#000
    style ABCA1_dysfunction_1 fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration fill:#4fc3f7,stroke:#333,color:#000
    style Lipidated_APOE fill:#4fc3f7,stroke:#333,color:#000
    style microglial_A__phagocytosi fill:#4fc3f7,stroke:#333,color:#000
    style Lipidated_APOE_2 fill:#4fc3f7,stroke:#333,color:#000
    style A__clearance fill:#4fc3f7,stroke:#333,color:#000
    style Elevated_ceramide_levels fill:#4fc3f7,stroke:#333,color:#000
    style AD_severity fill:#ef5350,stroke:#333,color:#000
    style Elevated_ceramide_levels_3 fill:#4fc3f7,stroke:#333,color:#000
    style cognitive_decline fill:#4fc3f7,stroke:#333,color:#000
    style S1P fill:#81c784,stroke:#333,color:#000
    style neuronal_survival fill:#4fc3f7,stroke:#333,color:#000
    style S1P_4 fill:#81c784,stroke:#333,color:#000
    style synaptic_plasticity fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — ST3GAL5

No curated PDB or AlphaFold mapping for ST3GAL5 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for ST3GAL5 →

No DepMap CRISPR Chronos data found for ST3GAL5.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.1%

💾 Resource Usage

LLM Tokens
12,502
$0.0750
Total Cost
$0.0750
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.